Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial.
Gillespie D, Butler CC, Bates J, Hood K, Melbye H, Phillips R, Stanton H, Alam MF, Cals JW, Cochrane A, Kirby N, Llor C, Lowe R, Naik G, Riga E, Sewell B, Thomas-Jones E, White P, Francis NA. Gillespie D, et al. Among authors: naik g. Br J Gen Pract. 2021 Mar 26;71(705):e266-e272. doi: 10.3399/BJGP.2020.0823. Print 2021 Apr. Br J Gen Pract. 2021. PMID: 33657007 Free PMC article. Clinical Trial.
General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J, Francis NA, White P, Gillespie D, Thomas-Jones E, Breen R, Kirby N, Hood K, Gal M, Phillips R, Naik G, Cals J, Llor C, Melbye H, Wootton M, Riga E, Cochrane A, Howe R, Fitzsimmons D, Sewell B, Alam MF, Butler CC. Bates J, et al. Among authors: naik g. Trials. 2017 Sep 29;18(1):442. doi: 10.1186/s13063-017-2144-8. Trials. 2017. PMID: 28969667 Free PMC article. Clinical Trial.
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.
Butler CC, Gillespie D, White P, Bates J, Lowe R, Thomas-Jones E, Wootton M, Hood K, Phillips R, Melbye H, Llor C, Cals JWL, Naik G, Kirby N, Gal M, Riga E, Francis NA. Butler CC, et al. Among authors: naik g. N Engl J Med. 2019 Jul 11;381(2):111-120. doi: 10.1056/NEJMoa1803185. N Engl J Med. 2019. PMID: 31291514 Clinical Trial.
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
Francis NA, Gillespie D, White P, Bates J, Lowe R, Sewell B, Phillips R, Stanton H, Kirby N, Wootton M, Thomas-Jones E, Hood K, Llor C, Cals J, Melbye H, Naik G, Gal M, Fitzsimmons D, Alam MF, Riga E, Cochrane A, Butler CC. Francis NA, et al. Among authors: naik g. Health Technol Assess. 2020 Mar;24(15):1-108. doi: 10.3310/hta24150. Health Technol Assess. 2020. PMID: 32202490 Free PMC article. Clinical Trial.
Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD.
Gillespie D, Francis N, Ahmed H, Hood K, Llor C, White P, Thomas-Jones E, Stanton H, Sewell B, Phillips R, Naik G, Melbye H, Lowe R, Kirby N, Cochrane A, Bates J, Alam MF, Butler C. Gillespie D, et al. Among authors: naik g. Int J Chron Obstruct Pulmon Dis. 2022 Feb 16;17:383-394. doi: 10.2147/COPD.S340710. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35210767 Free PMC article. Clinical Trial.
Communicating risk to patients and the public.
Naik G, Ahmed H, Edwards AG. Naik G, et al. Br J Gen Pract. 2012 Apr;62(597):213-6. doi: 10.3399/bjgp12X636236. Br J Gen Pract. 2012. PMID: 22520906 Free PMC article. No abstract available.
Cost of managing patients with venous leg ulcers.
Phillips CJ, Humphreys I, Thayer D, Elmessary M, Collins H, Roberts C, Naik G, Harding K. Phillips CJ, et al. Among authors: naik g. Int Wound J. 2020 Aug;17(4):1074-1082. doi: 10.1111/iwj.13366. Epub 2020 May 7. Int Wound J. 2020. PMID: 32383324 Free PMC article.
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, Török ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Voysey M, et al. Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. Lancet. 2021. PMID: 33617777 Free PMC article.
390 results